George Adel: Advancing Stroke Management at El Mabara Hospital Through Collaborative ICU Engagement
George Adel, Product Specialist at EVER Pharma (Africa), shared on LinkedIn:
”When you position yourself as a scientific resource rather than just a representative, you don’t just participate in the market you help shape it.
Today at El Mabara Hospital, it was all about partnering with the ICU team to elevate stroke management.
By aligning the clinical benefits of Cerebrolysin (right regimen) with the latest global guidelines, we aren’t just discussing a product, we are actively driving market growth and helping doctors optimize patient recovery.
A sincere thank you to Dr. Peter Wadie for always challenging me to grow and giving me the professional backing to execute these steps.
And to Dr. Sally Moheb, thank you for your encouragement and for always believing in my vision it really drives me to keep growing.”
Stay updated with Hemostasis Today.
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
-
May 18, 2026, 16:34Serah N. Gathu: Gaining Valuable Updates on ACS Management at the Africa STEMI Conference
-
May 18, 2026, 16:34Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
-
May 18, 2026, 16:33Dimitrios Kontothanassis: The Role of Thermal Ablation in GSV Reflux Treatment – LIVE 2026
-
May 18, 2026, 16:32Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
-
May 18, 2026, 16:28Reza Shojaei: The Global Plasma-to-Ig Supply Chain
-
May 18, 2026, 16:01Abdul Mannan: The Hardest Conversations in Myelofibrosis
-
May 18, 2026, 15:57Bridging Innovation and Access at the WFH 2026 World Congress – South African Haemophilia Foundation
-
May 18, 2026, 15:55Pierre François Sabouret: Network Meta-Analysis of Antithrombotic Therapy in Ischemic Stroke Patients